homephotos Newsmarket Newsstocks News

Delhivery, Gland Pharma, Sun Pharma: Tuesday's top brokerage calls

Delhivery, Gland Pharma, Sun Pharma: Tuesday's top brokerage calls

Delhivery, Gland Pharma, Sun Pharma: Tuesday's top brokerage calls
Read Time1 Min(s) Read
Profile image

By Sangam Singh  Nov 30, 2022 8:51:05 AM IST (Published)

Switch to Slide Show
Slide Show

SUMMARY

Morgan Stanley has an 'overweight' call on Delhivery with a target price of Rs 450 on its shares while Morgan Stanley has an 'overweight' call on Gland Pharma with a target price of Rs 2,558 on its shares.

CNBCTV18
Image count1 / 4

Delhivery | Morgan Stanley has an 'overweight' call on Delhivery with a target price of Rs 450 on its shares. The brokerage house says that competitive moats for logistics network and low-cost structure of the company is intact.

CNBCTV18
Image count2 / 4

Gland Pharma | Morgan Stanley has an 'overweight' call on Gland Pharma with a target price of Rs 2,558 on its shares. The brokerage house expects growth of the company to resume in FY24.

CNBCTV18
Image count3 / 4

Glenmark Pharma | Nomura has a 'buy' call on Glenmark Pharma with a target price of Rs 580 on its shares. The brokerage house says that company's growth and margin outlook higher than expectations.

CNBCTV18
Image count4 / 4

Sun Pharma | Macquarie has an 'outperform' call on Sun Pharma with a target price of Rs 1,275 on its shares. The brokerage house says that it expects FY25E EBITDA reaching to 30 percent.

Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
arrow down

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng